Joel Ackerman
Director, Coventry Health Care.
Companies
- DaVitaChief financial officer Feb 23, 2017 to now1
- Champions OncologyBoard member Oct 29, 2010 to now2
- Kindred HealthcareBoard member Dec 18, 2008 to Jul 2, 20183
- DaVitaSenior Vice President, Finance Feb 23, 2017 to Feb 23, 20174
- Champions OncologyChief executive officer Oct 29, 2010 to Nov 1, 20162
- Coventry Health CareBoard member Jan 4, 2006 to May 9, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
DaVita DVA132,434 shares6$24.8M at $187.12May 7, 2026
Champions Oncology CSBR1,056,539 shares7$5.0M at $4.70Oct 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- May 7, 2026Sold 51,471 shares at $192.10 of DaVita6
- Mar 15, 2026Shares withheld for tax 5,765 shares at $150.72 of DaVita8
- Mar 15, 2026Shares withheld for tax 33,693 shares at $150.72 of DaVita8
- Mar 15, 2026Shares withheld for tax 3,362 shares at $150.72 of DaVita8
- Mar 15, 2026Granted 5,706 shares of DaVita8
- Mar 10, 2026Granted 65,997 shares of DaVita9
- Mar 10, 2026Granted 6,585 shares of DaVita9
- Feb 6, 2026Shares withheld for tax 5,100 shares at $149.22 of DaVita10
- Feb 6, 2026Returned to company 32,168 shares at $149.22 of DaVita10
- Feb 6, 2026Exercised options 44,065 shares at $108.93 of DaVita10
- Oct 30, 2025Exercised options 94,405 shares at $2.10 of Champions Oncology7
- Mar 15, 2025Shares withheld for tax 3,331 shares at $143.45 of DaVita11
- Mar 15, 2025Shares withheld for tax 3,093 shares at $143.45 of DaVita11
- Mar 15, 2025Granted 5,995 shares of DaVita11
- Mar 12, 2025Granted 7,221 shares of DaVita12
- Mar 12, 2025Granted 7,394 shares of DaVita12
- Oct 31, 2024Exercised options 16,667 shares at $5.43 of Champions Oncology13
- Oct 31, 2024Exercised options 88,470 shares at $2.10 of Champions Oncology13
- Sep 16, 2024Shares withheld for tax 21,602 shares at $163.56 of DaVita14
- Sep 16, 2024Returned to company 36,684 shares at $163.56 of DaVita14
- Sep 16, 2024Exercised options 78,999 shares at $75.95 of DaVita14
- Aug 28, 2024Sold 4,740 shares at $155.02 of DaVita15
- Aug 27, 2024Sold 64,029 shares at $155.06 of DaVita15
- Mar 15, 2024Shares withheld for tax 8,064 shares at $136.00 of DaVita16
- Mar 15, 2024Granted 10,977 shares of DaVita16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDaVita, Chief financial officer
- 2SEC EDGARChampions Oncology, Board member
- 3SEC EDGARKindred Healthcare, Board member
- 4
- 5SEC EDGARCoventry Health Care, Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 17, 2026
- 9SEC EDGARForm 4 filed Mar 12, 2026
- 10SEC EDGARForm 4 filed Feb 9, 2026
- 11SEC EDGARForm 4 filed Mar 18, 2025
- 12SEC EDGARForm 4 filed Mar 14, 2025
- 13SEC EDGARForm 4 filed Nov 1, 2024
- 14SEC EDGARForm 4 filed Sep 17, 2024
- 15SEC EDGARForm 4 filed Aug 29, 2024
- 16SEC EDGARForm 4 filed Mar 18, 2024